Clinical Trials Directory

Trials / Sponsors / Cell Genesys

Cell Genesys

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
TerminatedDocetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
Prostate Cancer
Phase 32005-07-01
UnknownDose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
Carcinoma, Transitional Cell, Bladder Neoplasms
Phase 12005-04-01
TerminatedIntravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cance
Prostate Cancer
Phase 1 / Phase 22004-08-01
TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Pro
Prostate Cancer
Phase 32004-07-01
CompletedA Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cance
Lung Cancer, Carcinoma, Non-Small-Cell Lung
Phase 22003-03-01
CompletedA Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer, Nonresectable Pancreatic Cancer
Phase 22002-06-01
CompletedDose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
Prostate Cancer
Phase 1 / Phase 22001-12-01
CompletedVaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
Acute Myelogenous Leukemia
Phase 22001-03-01
CompletedVaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22000-10-01
CompletedPrime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell
Prostate Cancer
Phase 1 / Phase 21999-05-01
CompletedPrime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vacci
Prostate Cancer
Phase 1 / Phase 21999-05-01
CompletedVaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate
Prostate Cancer
Phase 1 / Phase 21998-12-01
CompletedTrial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer
Prostate Cancer
Phase 1 / Phase 2—